Patent ID: 7799784

Claim:
A compound of formula (I) and pharmaceutically acceptable salts or stereoisomers thereof, A—X 1 —Y—ONO 2 (I) wherein: A is X 1 has the following meanings: —C(O)—, —C(O)O—, Y is selected from the group consisting of: a) C 1 alkyl or straight or branched C 2 -C 20 alkylene, being optionally substituted with one or more of the substituents selected from the group consisting of: halogen atoms, hydroxy, —ONO 2 and T 0 , wherein T 0 is —OC(O)(C 1 -C 10 alkyl)—ONO 2 or —O(C 1 -C 10 alkyl)—ONO 2 ; or cycloalkylene with 5 to 7 carbon atoms in the cycloalkylene ring, the ring being optionally substituted with side chains T, wherein T is an alkyl with 1 carbon atom or a straight or branched alkyl with from 2 to 10 carbon atoms; where n is an integer from 0 to 20, n 1 is an integer from 1 to 20; wherein: n 1 is as defined above and n 2 is an integer from 0 to 2; X 2 =—OCO— or —COO— and R 2 is a hydrogen atom or CH 3 ; wherein: n 1 and n 2 , R 2 , and X 2 are as defined above; Y 1 is —CH 2 —CH 2 — or —CH═CH—(CH 2 )n 2 —; wherein: n 1 and R 2 are as defined above, R 3 is H or —COCH 3 ; with the proviso that when Y is one of b)-f), the —ONO 2 group is linked to a —(CH 2 ) n1 group; wherein X 3 is an oxygen atom or a sulphur atom, n 3 is an integer from 1 to 6, R 2 is as defined above; and wherein: n 4 is an integer from 0 to 10; n 5 is an integer from 1 to 10; R 4 , R 5 , R 6 , R 7 are the same or different, and are H or a C 1 alkyl or straight or branched C 2 -C 4 alkyl, wherein the —ONO 2 group is linked to wherein n 5 is as defined above; Y 2 is selected from the group consisting of: